Acute Youth Connect + TAU for Parasuicide

Phase-Based Progress Estimates
University of Rochester Medical Center, Rochester, NY
Parasuicide+1 More
Acute Youth Connect - Behavioral
< 65
All Sexes
What conditions do you have?

Study Summary

The purpose of this pilot study is to refine and then assess the feasibility, acceptability, and target engagement of Acute Youth Connect - a network health intervention for adolescents leaving acute psychiatric care with suicide-related concerns.

Eligible Conditions

  • Parasuicide

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 2 Secondary · Reporting Duration: Baseline to 3 months post-treatment, approximately 6 months

A text message must be responded to before the next text message prompt is sent (roughly one week).
Text message responses
Month 6
Change in feelings of meaning
Change in feelings of purpose
Change in perceived social connectedness
Change in weekly contact to supportive adults in their lives
Changes in access to emotion regulation strategies
Changes in engagement with healthy activities
Changes in interpersonal emotion regulation
Utilization of intervention content
Interactive sessions by the end of the 12-week intervention.
Number of youth who complete the intervention
Week 4
Adult support team treatment completion

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Acute Youth Connect + TAU
1 of 1
Experimental Treatment

60 Total Participants · 1 Treatment Group

Primary Treatment: Acute Youth Connect + TAU · No Placebo Group · N/A

Acute Youth Connect + TAU
Experimental Group · 1 Intervention: Acute Youth Connect · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to 3 months post-treatment, approximately 6 months

Trial Background

Ian Cero, Senior Instructor
Principal Investigator
University of Rochester
Closest Location: University of Rochester Medical Center · Rochester, NY
Photo of Rochester  1Photo of Rochester  2Photo of Rochester  3
2018First Recorded Clinical Trial
0 TrialsResearching Parasuicide
408 CompletedClinical Trials

Eligibility Criteria

Age < 65 · All Participants · 10 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You must be aged 12 - 18 years at time of enrollment.
You are at least 21 years of age.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.